RAKOVINA THERAPEUTICS INC (RKV.CA) Stock Overview
TSX-V:RKV - CA75103L1013 - Common Stock
RKV.CA Key Statistics, Chart & Performance
The current stock price of RKV.CA is 0.53 CAD. In the past month the price decreased by -13.11%. In the past year, price decreased by -44.21%.
About RKV.CA
Company Profile
Rakovina Therapeutics, Inc. focuses on the development of new cancer treatments based on novel DNA-damage response technologies. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2020-02-07. The firm is focused on the development of new cancer treatments based on novel deoxyribonucleic acid (DNA)-damage response technologies. Its drug development pipeline includes kt-2000AI and kt-3000 series. The company is engaged in employing the proprietary Deep Docking AI Platform to rapidly screen billions of potential drug candidates against PARP (kt-2000AI) and other novel DDR targets to generate drug candidates that can be advanced to human trials or developed in collaboration with pharmaceutical partners. Its kt-3000 series represents a novel class of bi-functional small-molecule drug candidates that has been designed to combine inhibition of both poly (ADP)-ribose polymerase (PARP) and histone deacetylase (HDAC) in a single molecule. This novel approach has the potential to overcome treatment resistance and provide clinical benefit to cancer patients.
Company Info
RAKOVINA THERAPEUTICS INC
105 - 1008 Beach Avenue
Vancouver BRITISH COLUMBIA V6B 0A5 CA
Employees: 0
Phone: 16046190225
RAKOVINA THERAPEUTICS INC / RKV.CA FAQ
What is the stock price of RAKOVINA THERAPEUTICS INC today?
The current stock price of RKV.CA is 0.53 CAD. The price increased by 6% in the last trading session.
What is the ticker symbol for RAKOVINA THERAPEUTICS INC stock?
The exchange symbol of RAKOVINA THERAPEUTICS INC is RKV and it is listed on the TSX Venture Exchange exchange.
On which exchange is RKV.CA stock listed?
RKV.CA stock is listed on the TSX Venture Exchange exchange.
What is RAKOVINA THERAPEUTICS INC worth?
RAKOVINA THERAPEUTICS INC (RKV.CA) has a market capitalization of 11.21M CAD. This makes RKV.CA a Nano Cap stock.
How many employees does RAKOVINA THERAPEUTICS INC have?
RAKOVINA THERAPEUTICS INC (RKV.CA) currently has 0 employees.
What are the support and resistance levels for RAKOVINA THERAPEUTICS INC (RKV.CA) stock?
RAKOVINA THERAPEUTICS INC (RKV.CA) has a support level at 0.5 and a resistance level at 0.57. Check the full technical report for a detailed analysis of RKV.CA support and resistance levels.
Should I buy RAKOVINA THERAPEUTICS INC (RKV.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of RKV.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of RKV.CA, evaluating the profitability, health, valuation and growth aspects
- RAKOVINA THERAPEUTICS INC (RKV.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- RAKOVINA THERAPEUTICS INC (RKV.CA) Sales and EPS estimates to see what analysts future expectations are.
- RAKOVINA THERAPEUTICS INC (RKV.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- RAKOVINA THERAPEUTICS INC (RKV.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- RAKOVINA THERAPEUTICS INC (RKV.CA) Stock Chart to make your own analysis
- RAKOVINA THERAPEUTICS INC (RKV.CA) Latest news and press-releases to stay up to date.
Does RAKOVINA THERAPEUTICS INC (RKV.CA) stock pay dividends?
RKV.CA does not pay a dividend.
When does RAKOVINA THERAPEUTICS INC (RKV.CA) report earnings?
RAKOVINA THERAPEUTICS INC (RKV.CA) will report earnings on 2025-08-28.
What is the Price/Earnings (PE) ratio of RAKOVINA THERAPEUTICS INC (RKV.CA)?
RAKOVINA THERAPEUTICS INC (RKV.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.53).
RKV.CA Technical Analysis
RKV.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to RKV.CA. RKV.CA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
RKV.CA Financial Highlights
Over the last trailing twelve months RKV.CA reported a non-GAAP Earnings per Share(EPS) of -0.53. The EPS decreased by -42.22% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -115.11% | ||
| ROE | -229.96% | ||
| Debt/Equity | 0 |